The first gene therapy for muscular dystrophy has been approved for some kids
The Food and Drug Administration cleared the therapy for use in 4- and 5-year-olds, for now
![A photo of a sign for the U.S. Department of Health and Human Services Food and Drug Administration.](https://i0.wp.com/www.sciencenews.org/wp-content/uploads/2023/06/062223_ts_muscular-dystrophy_feat.jpg?fit=1030%2C580&ssl=1)
The U.S. Food and Drug Administration has approved the first gene therapy for patients with Duchenne muscular dystrophy, a genetic disease that causes muscles to degenerate, eventually leading to death.
Sarah Silbiger/Getty Images